These observations, together with our siRNA experiments in HNSCC cell lines, suggest that in SCC at least, APOBEC3A expression is confined to the minority of tumour cells in which GRHL3 is expressed and active. The gene discussed is APOBEC3A; the disease is head and neck squamous cell carcinoma.